Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 2, 2024

Primary Completion Date

July 1, 2027

Study Completion Date

September 1, 2027

Conditions
Oral Cavity Squamous Cell Carcinoma
Interventions
DRUG

NisinZ® P

NisinZ® P is an ultrapure Nisin Z concentrate produced by fermentation using the bacterium Lactococcus lactis obtained from sauerkraut

PROCEDURE

Surgery (non-interventional, standard of care)

Surgical removal of tumor as part of standard of care treatment

Trial Locations (1)

94143

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

University of California, Los Angeles

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, San Francisco

OTHER